Slide Show: 2012 Who's Who in Infection Prevention

An infection preventionist examines the DRC’s Ebola response through contact tracing and community engagement, explaining why daily follow-up, timely investigations, and trust reveal challenges that cumulative case counts alone cannot capture.

Four vaccine experts discuss how sustained financing, local research leadership, and community trust can strengthen vaccine development in low- and middle-income countries (LMICs), drawing on practical insights from India and Bangladesh.

GeoVax CEO David Dodd discusses how vaccine storage requirements, supplier diversification, and regional manufacturing shape outbreak preparedness, with considerations for infection preventionists and health systems preparing to receive and administer doses.

Part 4 of 4: Why better planning for surgical growth, operational performance, and patient safety requires sterile processing expertise early in the decision-making process.

An emerging cause of sexually transmitted ringworm, TMVII can resemble other skin conditions and require prolonged treatment. Learn what clinicians and infection preventionists should know about recognition, specialized testing, and patient counseling.

3 of 4: How technology, artificial intelligence, automation, and data are reshaping sterile processing leadership

Part 2 of 4: Recruitment may bring people into sterile processing. Development is what determines whether they stay.

At IDWeek 2026, Rachel Sidebottom discusses research exploring phage-antibiotic combinations, the potential for predictive modeling, and an investigation identifying an ST5 strain of nontoxigenic Corynebacterium diphtheriae circulating in Albuquerque.